Correction: Another solid quarter with SEK 3 bn net sales, 23% adjusted EBITDA margin

Q3 net sales were stable year over year at SEK 2,988 million, while adjusted EBITDA rose 3% to SEK 693 million and its margin held at 23%. Reported EBITDA increased to SEK 688 million from SEK 590 million, EBIT to SEK 318 million from SEK 232 million, and net income to SEK 149 million from SEK 39 million. Operating cash flow was SEK 431 million, up from SEK 382 million; user-acquisition spending rose 6% to SEK 1,178 million.

Analysis

The quality of growth is less convincing than the headline earnings improvement: acquisition spending rose faster than sales, while adjusted EBITDA margin was unchanged. If that spend is buying users or customers, the key question is whether those cohorts monetize with a lag; without retention, payback, and organic-growth data, it is premature to call the increase either productive investment or deteriorating efficiency. The higher reported earnings alongside a much smaller rise in adjusted EBITDA also makes the adjustment bridge important: determine whether the gap reflects genuinely non-recurring items or recurring costs excluded from the adjusted measure.

Near term, the results support a mildly constructive read, but are not enough to establish a durable re-rating. Over the next 1–3 months, cohort returns, organic sales, and guidance on acquisition intensity should matter more than this quarter’s reported profit growth. Over 6–18 months, persistently higher acquisition intensity without faster sales growth would suggest weaker unit economics and could pressure both margins and valuation. The counterpoint is that spend may precede revenue and improve future cohorts; the supplied figures do not resolve that. Company identity and ticker are not provided, so no security-specific valuation or trade can be grounded.

Key Decisions for Investors

• No immediate directional trade on these figures alone. Treat the earnings signal as mildly positive but mixed; avoid extrapolating reported net-income growth into a higher run-rate.
• For the next earnings update, monitor organic sales, acquisition-spend share, cohort retention/payback, and guidance on spend. Evidence that sales growth accelerates while spend intensity stabilizes would support a more constructive view; continued flat sales with rising intensity would weaken it.
• Review the reconciliation from reported to adjusted earnings and cash conversion. A growing or recurring adjustment burden, or operating cash flow failing to track underlying earnings, would falsify the quality-improvement thesis.
• A security-specific long/short or options position requires the company identity, valuation, and peer set; until supplied, keep this as a watch item rather than a trade recommendation.